Investor relations expertise Solebury Strategic Communications specializes in investor relations and corporate communications for private and public companies, presenting a ready-made opportunity to expand into additional capital markets advisory services or expanded IR programs for clients in healthcare and life sciences.

Life sciences focus With a history of leadership moves in life sciences and a track record of working with healthcare clients, there is potential to package targeted IR, media relations, and investor targeting services for biotech, pharma, and medical device companies seeking visibility among investors.

Growth and scale Current revenue range and team size indicate a mid-market firm poised for expansion; potential buyers or partners include larger PR/IR firms seeking niche healthcare capabilities or clients looking to consolidate IR support during growth phases.

ESG and media assets Past collaboration on ESG webinars with NYSE signals readiness to scale ESG storytelling and investor education offerings, suggesting opportunities to upsell ESG-focused IR programs, thought leadership campaigns, and webinar-led investor outreach.

Cross-sell opportunities Existing technology stack and content platform familiarity (WordPress, SEO tools) can be leveraged to offer digital PR, content marketing, and investor education packages to current clients or new healthcare-focused firms seeking integrated communications solutions.